Is the risk of tenofovir-induced nephrotoxicity similar in treatment-naïve compared to treatment-experienced patients?
Background: Tenofovir disoproxil fumarate (TDF) is the recommended first-line nucleoside reverse transcriptase inhibitor (NRTI) in the management of human immunodeficiency virus (HIV); however, its use is associated with nephrotoxicity. Aim: To assess if the risks of renal impairment were similar in...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Wiley
2018
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/21392/ https://doi.org/10.1002/jppr.1392 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|